Literature DB >> 24942205

Oral vancomycin might be useful to suppress enteral VRE load: a conceptual experiment.

Joffrey van Prehn1, Annette M Stemerding, Hendrick K F Van Saene, Peter E Spronk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24942205     DOI： 10.1007/s00134-014-3365-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium.

Authors:  M R Weinstein; H Dedier; J Brunton; I Campbell; J M Conly
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

2.  Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.

Authors:  Wafa N Al-Nassir; Ajay K Sethi; Yuejin Li; Michael J Pultz; Michelle M Riggs; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

3.  Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci.

Authors:  P Van der Auwera; N Pensart; V Korten; B E Murray; R Leclercq
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

4.  Evaluation of zinc bacitracin capsules versus placebo for enteric eradication of vancomycin-resistant Enterococcus faecium.

Authors:  K E Mondy; W Shannon; L M Mundy
Journal:  Clin Infect Dis       Date:  2001-07-06       Impact factor: 9.079

5.  Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile.

Authors:  Cassandra D Salgado; Eve T Giannetta; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2004-05       Impact factor: 3.254
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.